1,474 results on '"MS"'
Search Results
2. RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial: Study rationale and design
3. Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
4. Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial
5. Design and rationale of the social determinants of the risk of hypertension in women of reproductive age (SAFE HEART) study: An American Heart Association research goes red initiative
6. Real-world exploration of LDL-cholesterol management in patients with atherosclerotic cardiovascular disease
7. Design and rationale of penn medicine healthy heart, a randomized trial of effectiveness of a centrally organized approach to blood pressure and cholesterol improvement among patients at elevated risk of atherosclerotic cardiovascular disease
8. Contributors to high left ventricular ejection fraction in women with ischemia and no obstructive coronary artery disease: Results from the Women's Ischemia Syndrome Evaluation—Coronary Vascular Dysfunction (WISE-CVD) Study
9. Variations in antihypertensive medication treatment and blood pressure control among Veterans with HIV and existing hypertension
10. Examining lack of referrals to heart valve specialists as mechanisms of potential underutilization of aortic valve replacement
11. Design and rationale of the Comprehensive intelligent Hypertension managEment SyStem (CHESS) evaluation study: A cluster randomized controlled trial for hypertension management in primary care
12. Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2)
13. Comparing the outcomes of rheumatic heart disease in pregnancy complicated with and without atrial fibrillation: A propensity score matched analysis
14. Assessment of the CLOT (children's likelihood of thrombosis) real-time risk prediction model of hospital-associated venous thromboembolism in children with congenital heart disease
15. Prognostic implications of volume status assessed by blood volume analysis in ambulatory heart failure
16. Angiographic characteristics of patients with STEMI and COVID-19: Insights from NACMI registry
17. Characterizing advanced heart failure risk and hemodynamic phenotypes using interpretable machine learning
18. Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study
19. Radial artery vs right internal mammary artery as a second conduit during coronary artery bypass grafting
20. Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI
21. Study of heart function in PRE-Eclampsia during and after PreGnancy (SHePREG): The pilot cohort
22. Unfavorable social determinants of health and mortality risk by cardiovascular disease status: Findings from a National Study of United States Adults
23. Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial—rationale and design
24. Investigating racial and gender disparities in virtual randomized clinical trial enrollment: Insights from the BE ACTIVE study
25. Cardiovascular event reduction among a US population eligible for semaglutide per the SELECT trial
26. Race, hypertensive disorders of pregnancy and outcomes in peripartum cardiomyopathy
27. Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study
28. Framework of the strengths and challenges of clinically integrated trials: An expert panel report
29. Incident stroke in individuals with peripartum cardiomyopathy
30. Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50%
31. Overview of 2024 FDA Advisory Panel Meeting on the TriClip transcatheter tricuspid valve repair system
32. Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosis
33. Effects of fortified eggs and time-restricted eating on cardiometabolic health: The prosperity trial
34. Antihypertensive medication prescription dispensation among pregnant women in the United States: A cohort study
35. Enrollment strategies in the era of digital revolution: Experience from a remote health management program
36. Trends in cancer and heart failure related mortality in adult US population: A CDC WONDER database analysis from 1999 to 2020
37. Rationale and design of CHD PULSE: Congenital Heart Disease Project to Understand Lifelong Survivor Experience
38. Assessing methods to ascertain persistence and adherence of oral anticoagulants in patients with atrial fibrillation
39. Rule-based natural language processing to examine variation in worsening heart failure hospitalizations by age, sex, race and ethnicity, and left ventricular ejection fraction
40. Center-level factors associated with shorter length of stay following stage 1 palliation: An analysis of the national pediatric cardiology quality improvement collaborative registry
41. A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH)
42. Association between racial residential segregation and Black-White disparities in cardiovascular disease mortality
43. Cardiac imaging and biomarkers for assessing myocardial fibrosis in children with hypertrophic cardiomyopathy
44. Sociodemographic disparities in the use of cardiovascular ambulatory care and telemedicine during the COVID-19 pandemic
45. Epidemiologic trends and risk factors associated with the decline in mortality from coronary heart disease in the United States, 1990-2019
46. Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registry
47. The effects of pregnancy in subjects with repaired tetralogy of Fallot
48. Premorbid physical activity and prognosis after incident myocardial infarction: The atherosclerosis risk in communities study
49. Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN
50. Association of patient-level characteristics with long-term outcomes after Fontan palliation: Rationale, design, and baseline characteristics of the Pediatric Cardiac Care Consortium Fontan cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.